GeoVax Labs (NASDAQ:GOVX) Stock Price Up 0.6%

GeoVax Labs, Inc. (NASDAQ:GOVX)’s stock price shot up 0.6% during trading on Wednesday . The company traded as high as $1.70 and last traded at $1.63. 9,813 shares changed hands during trading, a decline of 74% from the average session volume of 37,163 shares. The stock had previously closed at $1.62.

GeoVax Labs Stock Performance

The stock has a market cap of $3.77 million, a PE ratio of -0.12 and a beta of 2.91. The company has a 50 day moving average of $1.86 and a two-hundred day moving average of $4.12.

Institutional Investors Weigh In On GeoVax Labs

An institutional investor recently bought a new position in GeoVax Labs stock. Armistice Capital LLC bought a new position in shares of GeoVax Labs, Inc. (NASDAQ:GOVX) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 1,626,516 shares of the company’s stock, valued at approximately $587,000. Armistice Capital LLC owned approximately 91.38% of GeoVax Labs at the end of the most recent reporting period. Hedge funds and other institutional investors own 6.09% of the company’s stock.

GeoVax Labs Company Profile

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers.